C
5.71
0.06 (1.06%)
| Previous Close | 5.65 |
| Open | 5.65 |
| Volume | 20,597 |
| Avg. Volume (3M) | 69,595 |
| Market Cap | 95,499,752 |
| Price / Sales | 24.23 |
| Price / Book | 2.83 |
| 52 Weeks Range |
| Operating Margin (TTM) | -2,976.89% |
| Diluted EPS (TTM) | -1.07 |
| Quarterly Revenue Growth (YOY) | 103.30% |
| Current Ratio (MRQ) | 8.84 |
| Operating Cash Flow (TTM) | -15.26 M |
| Levered Free Cash Flow (TTM) | -10.29 M |
| Return on Assets (TTM) | -32.06% |
| Return on Equity (TTM) | -52.11% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bearish | Bearish |
| Biotechnology (Global) | Bearish | Bearish | |
| Stock | Coya Therapeutics, Inc. | Mixed | Mixed |
AIStockmoo Score
1.3
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -2.5 |
| Average | 1.25 |
|
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 7.02% |
| % Held by Institutions | 28.05% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Dme Capital Management, Lp | 31 Mar 2025 | 1,646,440 |
| Aigh Capital Management Llc | 31 Mar 2025 | 1,183,780 |
| Cm Management, Llc | 31 Mar 2025 | 200,000 |
| Ghp Investment Advisors, Inc. | 31 Mar 2025 | 26,171 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 18.00 (D. Boral Capital, 215.24%) | Buy |
| Median | 16.00 (180.21%) | |
| Low | 14.00 (Chardan Capital, 145.18%) | Buy |
| Average | 16.00 (180.21%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 6.15 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Chardan Capital | 13 May 2025 | 14.00 (145.18%) | Buy | 5.76 |
| 28 Apr 2025 | 14.00 (145.18%) | Buy | 6.17 | |
| D. Boral Capital | 24 Apr 2025 | 18.00 (215.24%) | Buy | 6.53 |
| 22 Apr 2025 | 18.00 (215.24%) | Buy | 6.64 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |